Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane and its negatively charged surface components, such as phospholipids (e.g., phosphatidylglycerol and cardiolipin) and lipopolysaccharides (LPS), serve as critical structural and functional barriers for the cell. These components maintain the physical integrity of the bacterium, regulate the transport of ions and nutrients, and provide a scaffold for essential metabolic processes. In Gram-negative bacteria, the outer membrane is rich in LPS, while Gram-positive bacteria possess a thick peptidoglycan layer associated with lipoteichoic acids (LTA). These negatively charged molecules are primary targets for several classes of antibiotics, including polymyxins and lipopeptides like daptomycin. These drugs typically interact with the membrane through electrostatic attraction to the anionic surfaces, followed by hydrophobic insertion into the lipid bilayer. This process leads to membrane permeabilization, depolarization, and the leakage of intracellular contents, ultimately resulting in rapid bacterial cell death. Because these targets are fundamental to bacterial survival and differ significantly from eukaryotic membranes, they are highly effective sites for antimicrobial intervention, particularly against multidrug-resistant pathogens.
Drugs targeting these components typically utilize electrostatic interactions to bind to negatively charged surfaces (such as the phosphate groups of LPS or anionic phospholipids like PG), followed by hydrophobic insertion into the lipid bilayer. This leads to membrane destabilization, pore formation, depolarization, and the leakage of essential intracellular contents, ultimately resulting in rapid bactericidal activity.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane phospholipids and negatively charged cell surface components.